1 He was diagnosed in 2003 with acute myelogenous leukemia.

2 Acute myelogenous leukemia is a series of diseases involving the white blood cells.

3 Acute lymphocytic leukemia and acute myelogenous leukemia are each composed of blast cells, known as lymphoblasts or myeloblasts.

4 In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL), the original acute leukemia cell goes on to form about a trillion more leukemia cells.

5 Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow — the spongy tissue inside bones where blood cells are made.

6 In chronic myelogenous leukemia, the target of these drugs is the protein produced by the BCR-ABL gene — tyrosine kinase.

7 Chronic myelogenous leukemia ( CML ) is a clonal myeloproliferative disease of transformed hematopoietic progenitor cells.

8 "Acute lymphocytic leukemia" and "acute myelogenous leukemia" are each composed of young cells, known as "lymphoblasts" or "myeloblasts. " These cells are sometimes called "blasts.

9 Chronic lymphocytic leukemia and chronic myelogenous leukemia usually progress slowly compared to acute leukemias.

10 "Acute lymphocytic leukemia" and "acute myelogenous leukemia" are each composed of young cells, known as "lymphoblasts" or "myeloblasts.

11 "Chronic" leukemias have few or no blast cells. "Chronic lymphocytic leukemia" and "chronic myelogenous leukemia" usually progress slowly compared to acute leukemias.

12 DNA repair enzyme inhibitors , which are derived from toxins found in certain plants, can cause acute myelogenous leukemia and myelodysplastic syndromes.

13 At high power, the bone marrow of a patient with acute myelogenous leukemia is seen here. There is one lone megakaryocyte at the right center.

14 Objective To determine the distribution of reticulin fibre and megakaryocyte in bone marrow biopsy(Trephine biopsy)of chronic myelogenous leukemia (CML).

15 In an embodiment of the fourth aspect, the malignancy is myelogenous leukemia.

16 Objective To investigate the complications of intensive chemotherapy of high dose cytarabine in patients with acute myelogenous leukemia.

17 AIM: To study the effects and mechanism of mitogen activated protein kinase (MAPK) in cell signal transduction of chronic myelogenous leukemia (CML).

18 COMPARISON OF CYTOKINE GENES AND ONCOGENES EXPRESSION BETWEEN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA M 2 a AND M 2 b.

19 Procarbazine, nitrogen mustard, and ifosfamide, which can increase risk for myelodysplastic syndromes and acute myelogenous leukemia.

20 Granulocytic sarcomas, also known as chloromas, are extramedullary masses in patients with myelogenous leukemia.

21 Finally, phagocyte precursors may undergo malignant transformation, which results in acute or chronic myelogenous leukemia.